#2
| |||
| |||
Re: NDRI Drugs
A norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug that acts as a reuptake inhibitor for the neurotransmitters norepinephrine and dopamine by blocking the action of the norepinephrine transporter (NET) and the dopamine transporter (DAT), respectively. Many NDRIs exist, including the following: Amineptine (Survector, Maneon, Directim) Bupropion (Wellbutrin) Desoxypipradrol (2-DPMP) Dexmethylphenidate (Focalin) Difemetorex (Cleofil) Diphenylprolinol (D2PM) Ethylphenidate Fencamfamine (Glucoenergan, Reactivan) Fencamine (Altimina, Sicoclor) Lefetamine (Santenol) Methylenedioxypyrovalerone (MDPV) Methylphenidate (Ritalin, Concerta, Metadate, Methylin, Rubifen, Stimdate) Nomifensine (Merital) O-2172 Oxolinic acid Pipradrol (Meretran) Prolintane (Promotil, Katovit) Pyrovalerone (Centroton, Thymergix) Tametraline (CP-24,411) WY-46824 |